<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>6733873</pmcid><all-ids><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="pmid">31501482</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="pmc">6733873</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="publisher-id">49360</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="doi">10.1038/s41598-019-49360-1</article-id></all-ids><extracted-table><table-id>Tab1</table-id><table-label>Table 1</table-label><table-caption>Subject data.</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab1"><label>Table 1</label><caption><p>Subject data.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2"/><th rowspan="2">Subject No.</th><th rowspan="2">Age</th><th rowspan="2">Sex</th><th rowspan="2">Diagnosis</th><th rowspan="2">Dosage of ketamine (mg/kg)</th><th rowspan="2">Medication</th><th colspan="4">Clinical Scores Pre - Post Ketamine</th></tr><tr><th>NRS</th><th>HADS-D</th><th>HADS-A</th><th>PCS</th></tr></thead><tbody><tr><td rowspan="12">Group R</td><td>1</td><td>52</td><td>M</td><td>TCS</td><td>0.299</td><td>Tra, Gab</td><td>4 - 1</td><td>15 - 12</td><td>4 - 0</td><td>22 - 20</td></tr><tr><td>2</td><td>45</td><td>F</td><td>FPD</td><td>0.300</td><td>Pgb, Dul</td><td>9 - 1</td><td>6 - 1</td><td>5 - 0</td><td>33 - 19</td></tr><tr><td>3</td><td>79</td><td>M</td><td>PHN</td><td>0.301</td><td>Pgb, Ami</td><td>5 - 0</td><td>10 - 1</td><td>9 - 3</td><td>19 - 14</td></tr><tr><td>4</td><td>31</td><td>M</td><td>TCS</td><td>0.295</td><td>Pgb, Dul</td><td>9 - 2</td><td>18 - 18</td><td>17 - 9</td><td>48 - 36</td></tr><tr><td>5</td><td>50</td><td>M</td><td>LSS</td><td>0.303</td><td>Dul</td><td>3 - 1</td><td>12 - 11</td><td>12 - 11</td><td>48 - 42</td></tr><tr><td>6</td><td>74</td><td>M</td><td>PHN</td><td>0.294</td><td>Pgb, Dul</td><td>5 - 2</td><td>7 - 7</td><td>1 - 1</td><td>36 - 30</td></tr><tr><td>7</td><td>81</td><td>F</td><td>PHN</td><td>0.303</td><td>Tra</td><td>6 - 0</td><td>7 - 3</td><td>1 - 2</td><td>42 - 34</td></tr><tr><td>8</td><td>66</td><td>M</td><td>LSS</td><td>0.309</td><td>—</td><td>5 - 2</td><td>0 - 3</td><td>0 - 7</td><td>36 - 38</td></tr><tr><td>9</td><td>68</td><td>M</td><td>PTPS</td><td>0.308</td><td>Tra</td><td>4 - 2</td><td>13 - 11</td><td>12 - 13</td><td>44 - 44</td></tr><tr><td>10</td><td>77</td><td>M</td><td>PHN</td><td>0.300</td><td>Pgb, Dul</td><td>4 - 0</td><td>6 - 3</td><td>0 - 2</td><td>26 - 15</td></tr><tr><td>11</td><td>27</td><td>M</td><td>FPD</td><td>0.298</td><td>Pgb</td><td>7 - 3</td><td>10 - 9</td><td>5 - 4</td><td>28 - 27</td></tr><tr><td>12</td><td>49</td><td>F</td><td>FPD</td><td>0.308</td><td>Pgb, Dul</td><td>5 - 0</td><td>4 - 0</td><td>7 - 1</td><td>16 - 3</td></tr><tr><td rowspan="12">Group NR</td><td>13</td><td>50</td><td>M</td><td>TCS</td><td>0.298</td><td>Tra, Gab, Dul</td><td>5 - 4</td><td>1 - 0</td><td>6 - 0</td><td>30 - 26</td></tr><tr><td>14</td><td>66</td><td>M</td><td>FPD</td><td>0.308</td><td>Tra</td><td>3 - 2</td><td>6 - 1</td><td>5 - 0</td><td>36 - 18</td></tr><tr><td>15</td><td>58</td><td>F</td><td>FBSS</td><td>0.306</td><td>Tra, Pgb</td><td>5 - 3</td><td>6 - 1</td><td>9 - 9</td><td>29 - 35</td></tr><tr><td>16</td><td>23</td><td>F</td><td>TCS</td><td>0.299</td><td>—</td><td>7 - 5</td><td>13 - 10</td><td>11 - 4</td><td>37 - 33</td></tr><tr><td>17</td><td>70</td><td>M</td><td>PHN</td><td>0.308</td><td>Pgb, Dul</td><td>4 - 4</td><td>1 - 2</td><td>3 - 5</td><td>23 - 25</td></tr><tr><td>18</td><td>68</td><td>M</td><td>LSS</td><td>0.300</td><td>Tra</td><td>4 - 3</td><td>6 - 0</td><td>5 - 0</td><td>12 - 6</td></tr><tr><td>19</td><td>43</td><td>M</td><td>TCS</td><td>0.294</td><td>Tra, Pgb</td><td>3 - 2</td><td>1 - 1</td><td>3 - 1</td><td>21 - 15</td></tr><tr><td>20</td><td>57</td><td>M</td><td>FPD</td><td>0.299</td><td>—</td><td>9 - 6</td><td>7 - 4</td><td>7 - 0</td><td>50 - 44</td></tr><tr><td>21</td><td>29</td><td>M</td><td>FBSS</td><td>0.299</td><td>Dul</td><td>4 - 3</td><td>6 - 12</td><td>2 - 10</td><td>26 - 40</td></tr><tr><td>22</td><td>46</td><td>M</td><td>CS</td><td>0.300</td><td>Dul</td><td>3 - 3</td><td>8 - 7</td><td>7 - 8</td><td>35 - 34</td></tr><tr><td>23</td><td>78</td><td>M</td><td>LSS</td><td>0.294</td><td>Pgb, Dul</td><td>10-/6</td><td>9 - 2</td><td>14 - 11</td><td>47 - 46</td></tr><tr><td>24</td><td>53</td><td>M</td><td>CRPS</td><td>0.307</td><td>—</td><td>3 - 3</td><td>7 - 6</td><td>9 - 3</td><td>24 - 21</td></tr><tr><td/><td>Mean</td><td/><td/><td/><td/><td/><td>5.3 - 2.4</td><td>7.5 - 5.2</td><td>6.4 - 4.5</td><td>32 - 28</td></tr><tr><td/><td/><td/><td/><td/><td/><td/><td><italic>p</italic> &lt; 0.05</td><td><italic>p</italic> &lt; 0.05</td><td><italic>p</italic> &lt; 0.05</td><td><italic>p</italic> &lt; 0.05</td></tr></tbody></table><table-wrap-foot><p>Paired <italic>t</italic>-test showed a significant difference between pre-post-ketamine scores on NRS, HADS-A, HADS-D, and PCS (<italic>p</italic> &lt; 0.05). Twelve (three females) patients showed an improvement in NRS score of ≥50% following ketamine treatment and were classified into Group R. The remaining 12 (two females) were classified into Group NR.</p><p>Group R: Responders, Group NR: Non-responders.</p><p>TCS, traumatic cervical syndrome; FPD, functional pain disorders; PHN, post-herpetic neuralgia; LSS, lumbar spinal canal stenosis; PTPS, post-thoracotomy pain syndrome; FBSS, failed back surgery syndrome; CS, cervical spondylosis.</p><p>Tra, tramadol; Gab, gabapentin; Pgb, pregabalin; Dul, duloxetine; Ami, amitriptyline</p><p>NRS (Numerical Rating Scale): 0 = “no pain” and 10 = “the worst pain imaginable”. HADS-A (Hospital Anxiety and Depression Scale-Anxiety). HADS-D (Hospital Anxiety and Depression Scale-Depression). PCS (Pain Catastrophizing Scale).</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Subject data.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th rowspan="2"/><th rowspan="2">Subject No.</th><th rowspan="2">Age</th><th rowspan="2">Sex</th><th rowspan="2">Diagnosis</th><th rowspan="2">Dosage of ketamine (mg/kg)</th><th rowspan="2">Medication</th><th colspan="4">Clinical Scores Pre - Post Ketamine</th></tr><tr><th>NRS</th><th>HADS-D</th><th>HADS-A</th><th>PCS</th></tr></thead><tbody><tr><td rowspan="12">Group R</td><td>1</td><td>52</td><td>M</td><td>TCS</td><td>0.299</td><td>Tra, Gab</td><td>4 - 1</td><td>15 - 12</td><td>4 - 0</td><td>22 - 20</td></tr><tr><td>2</td><td>45</td><td>F</td><td>FPD</td><td>0.300</td><td>Pgb, Dul</td><td>9 - 1</td><td>6 - 1</td><td>5 - 0</td><td>33 - 19</td></tr><tr><td>3</td><td>79</td><td>M</td><td>PHN</td><td>0.301</td><td>Pgb, Ami</td><td>5 - 0</td><td>10 - 1</td><td>9 - 3</td><td>19 - 14</td></tr><tr><td>4</td><td>31</td><td>M</td><td>TCS</td><td>0.295</td><td>Pgb, Dul</td><td>9 - 2</td><td>18 - 18</td><td>17 - 9</td><td>48 - 36</td></tr><tr><td>5</td><td>50</td><td>M</td><td>LSS</td><td>0.303</td><td>Dul</td><td>3 - 1</td><td>12 - 11</td><td>12 - 11</td><td>48 - 42</td></tr><tr><td>6</td><td>74</td><td>M</td><td>PHN</td><td>0.294</td><td>Pgb, Dul</td><td>5 - 2</td><td>7 - 7</td><td>1 - 1</td><td>36 - 30</td></tr><tr><td>7</td><td>81</td><td>F</td><td>PHN</td><td>0.303</td><td>Tra</td><td>6 - 0</td><td>7 - 3</td><td>1 - 2</td><td>42 - 34</td></tr><tr><td>8</td><td>66</td><td>M</td><td>LSS</td><td>0.309</td><td>—</td><td>5 - 2</td><td>0 - 3</td><td>0 - 7</td><td>36 - 38</td></tr><tr><td>9</td><td>68</td><td>M</td><td>PTPS</td><td>0.308</td><td>Tra</td><td>4 - 2</td><td>13 - 11</td><td>12 - 13</td><td>44 - 44</td></tr><tr><td>10</td><td>77</td><td>M</td><td>PHN</td><td>0.300</td><td>Pgb, Dul</td><td>4 - 0</td><td>6 - 3</td><td>0 - 2</td><td>26 - 15</td></tr><tr><td>11</td><td>27</td><td>M</td><td>FPD</td><td>0.298</td><td>Pgb</td><td>7 - 3</td><td>10 - 9</td><td>5 - 4</td><td>28 - 27</td></tr><tr><td>12</td><td>49</td><td>F</td><td>FPD</td><td>0.308</td><td>Pgb, Dul</td><td>5 - 0</td><td>4 - 0</td><td>7 - 1</td><td>16 - 3</td></tr><tr><td rowspan="12">Group NR</td><td>13</td><td>50</td><td>M</td><td>TCS</td><td>0.298</td><td>Tra, Gab, Dul</td><td>5 - 4</td><td>1 - 0</td><td>6 - 0</td><td>30 - 26</td></tr><tr><td>14</td><td>66</td><td>M</td><td>FPD</td><td>0.308</td><td>Tra</td><td>3 - 2</td><td>6 - 1</td><td>5 - 0</td><td>36 - 18</td></tr><tr><td>15</td><td>58</td><td>F</td><td>FBSS</td><td>0.306</td><td>Tra, Pgb</td><td>5 - 3</td><td>6 - 1</td><td>9 - 9</td><td>29 - 35</td></tr><tr><td>16</td><td>23</td><td>F</td><td>TCS</td><td>0.299</td><td>—</td><td>7 - 5</td><td>13 - 10</td><td>11 - 4</td><td>37 - 33</td></tr><tr><td>17</td><td>70</td><td>M</td><td>PHN</td><td>0.308</td><td>Pgb, Dul</td><td>4 - 4</td><td>1 - 2</td><td>3 - 5</td><td>23 - 25</td></tr><tr><td>18</td><td>68</td><td>M</td><td>LSS</td><td>0.300</td><td>Tra</td><td>4 - 3</td><td>6 - 0</td><td>5 - 0</td><td>12 - 6</td></tr><tr><td>19</td><td>43</td><td>M</td><td>TCS</td><td>0.294</td><td>Tra, Pgb</td><td>3 - 2</td><td>1 - 1</td><td>3 - 1</td><td>21 - 15</td></tr><tr><td>20</td><td>57</td><td>M</td><td>FPD</td><td>0.299</td><td>—</td><td>9 - 6</td><td>7 - 4</td><td>7 - 0</td><td>50 - 44</td></tr><tr><td>21</td><td>29</td><td>M</td><td>FBSS</td><td>0.299</td><td>Dul</td><td>4 - 3</td><td>6 - 12</td><td>2 - 10</td><td>26 - 40</td></tr><tr><td>22</td><td>46</td><td>M</td><td>CS</td><td>0.300</td><td>Dul</td><td>3 - 3</td><td>8 - 7</td><td>7 - 8</td><td>35 - 34</td></tr><tr><td>23</td><td>78</td><td>M</td><td>LSS</td><td>0.294</td><td>Pgb, Dul</td><td>10-/6</td><td>9 - 2</td><td>14 - 11</td><td>47 - 46</td></tr><tr><td>24</td><td>53</td><td>M</td><td>CRPS</td><td>0.307</td><td>—</td><td>3 - 3</td><td>7 - 6</td><td>9 - 3</td><td>24 - 21</td></tr><tr><td/><td>Mean</td><td/><td/><td/><td/><td/><td>5.3 - 2.4</td><td>7.5 - 5.2</td><td>6.4 - 4.5</td><td>32 - 28</td></tr><tr><td/><td/><td/><td/><td/><td/><td/><td>p &lt; 0.05</td><td>p &lt; 0.05</td><td>p &lt; 0.05</td><td>p &lt; 0.05</td></tr></tbody></table></div>Paired t-test showed a significant difference between pre-post-ketamine scores on NRS, HADS-A, HADS-D, and PCS (p &lt; 0.05). Twelve (three females) patients showed an improvement in NRS score of ≥50% following ketamine treatment and were classified into Group R. The remaining 12 (two females) were classified into Group NR.Group R: Responders, Group NR: Non-responders.TCS, traumatic cervical syndrome; FPD, functional pain disorders; PHN, post-herpetic neuralgia; LSS, lumbar spinal canal stenosis; PTPS, post-thoracotomy pain syndrome; FBSS, failed back surgery syndrome; CS, cervical spondylosis.Tra, tramadol; Gab, gabapentin; Pgb, pregabalin; Dul, duloxetine; Ami, amitriptylineNRS (Numerical Rating Scale): 0 = “no pain” and 10 = “the worst pain imaginable”. HADS-A (Hospital Anxiety and Depression Scale-Anxiety). HADS-D (Hospital Anxiety and Depression Scale-Depression). PCS (Pain Catastrophizing Scale).</transformed-table></extracted-table><extracted-table><table-id>Tab2</table-id><table-label>Table 2</table-label><table-caption>Summary of subject data and clinical scores of Group R and Group NR prior to the treatment.</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab2"><label>Table 2</label><caption><p>Summary of subject data and clinical scores of Group R and Group NR prior to the treatment.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2"/><th rowspan="2">n</th><th rowspan="2">Age (years)</th><th rowspan="2">Dosage of ketamine<break/>(mg/kg)</th><th colspan="4">Pre ketamine clinical score (mean ± SEM)</th></tr><tr><th>NRS</th><th>HADS-D</th><th>HADS-A</th><th>PCS</th></tr></thead><tbody><tr><td>Group R</td><td>12 (3 female)</td><td>58 ± 5.3</td><td>0.301 ± 0.0014</td><td>5.5 ± 0.5</td><td>9 ± 1.4</td><td>6.0 ± 1.5</td><td>33 ± 3.1</td></tr><tr><td>Group NR</td><td>12 (2 female)</td><td>53 ± 4.7</td><td>0.300 ± 0.0014</td><td>5 ± 0.6</td><td>5.9 ± 1.0</td><td>6.7 ± 1.0</td><td>31 ± 3.1</td></tr><tr><td/><td/><td><italic>p</italic> = 0.50</td><td><italic>p</italic> = 0.77</td><td><italic>p</italic> = 0.58</td><td><italic>p</italic> = 0.09</td><td><italic>p</italic> = 0.70</td><td><italic>p</italic> = 0.60</td></tr></tbody></table><table-wrap-foot><p>There was no significant difference in terms of age, dosage of ketamine, pre-treatment NRS, HADS, and PCS between Group R and Group NR.</p><p>Group R: responders, Group NR: non-responders. NRS (Numerical Rating Scale): 0 = “no pain” and 10 = “the worst pain imaginable”. HADS-A (Hospital Anxiety and Depression Scale-Anxiety). HADS-D (Hospital Anxiety and Depression Scale-Depression). PCS (Pain Catastrophizing Scale).</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 2<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Summary of subject data and clinical scores of Group R and Group NR prior to the treatment.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th rowspan="2"/><th rowspan="2">n</th><th rowspan="2">Age (years)</th><th rowspan="2">Dosage of ketamine(mg/kg)</th><th colspan="4">Pre ketamine clinical score (mean ± SEM)</th></tr><tr><th>NRS</th><th>HADS-D</th><th>HADS-A</th><th>PCS</th></tr></thead><tbody><tr><td>Group R</td><td>12 (3 female)</td><td>58 ± 5.3</td><td>0.301 ± 0.0014</td><td>5.5 ± 0.5</td><td>9 ± 1.4</td><td>6.0 ± 1.5</td><td>33 ± 3.1</td></tr><tr><td>Group NR</td><td>12 (2 female)</td><td>53 ± 4.7</td><td>0.300 ± 0.0014</td><td>5 ± 0.6</td><td>5.9 ± 1.0</td><td>6.7 ± 1.0</td><td>31 ± 3.1</td></tr><tr><td/><td/><td>p = 0.50</td><td>p = 0.77</td><td>p = 0.58</td><td>p = 0.09</td><td>p = 0.70</td><td>p = 0.60</td></tr></tbody></table></div>There was no significant difference in terms of age, dosage of ketamine, pre-treatment NRS, HADS, and PCS between Group R and Group NR.Group R: responders, Group NR: non-responders. NRS (Numerical Rating Scale): 0 = “no pain” and 10 = “the worst pain imaginable”. HADS-A (Hospital Anxiety and Depression Scale-Anxiety). HADS-D (Hospital Anxiety and Depression Scale-Depression). PCS (Pain Catastrophizing Scale).</transformed-table></extracted-table></extracted-tables-set>